Filing Details

Accession Number:
0001181431-13-015497
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-07 21:06:24
Reporting Period:
2013-03-06
Filing Date:
2013-03-07
Accepted Time:
2013-03-07 21:06:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389870 Omni Bio Pharmaceutical Inc. OMBP Biological Products, (No Disgnostic Substances) (2836) 208097969
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1011938 Mark Steven Bathgate 5350 South Roslyn
Suite 430
Greenwood Village CO 80111
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-03-06 300,000 $0.25 417,750 No 4 S Indirect By GVC Partners LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By GVC Partners LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 202,355 Direct
Common Stock 100,000 Indirect By GVC Capital LLC
Common Stock 30,000 Indirect By Bathgate Family Partnership Ltd.
Common Stock 604,000 Indirect By wife
Common Stock 50,000 Indirect By daughter
Footnotes
  1. The reporting person is a Senior Managing Partner of GVC Partners LLC. GVC Partners LLC is the sole member of GVC Capital LLC.
  2. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of such securities for purposes of Section 16 or for any other purpose.
  3. On March 6, 2013, GVC Partners LLC sold 100,000 shares of the issuer's common stock to GVC Capital LLC and 100,000 shares of the issuer's common stock to the reporting person. These transaction are treated soley as a change in the form of beneficial ownership of the reporting person.